Bilinear softening parameters and equivalent LEFM R-curve in quasibrittle failure

For composites and adhesive joints, the determination of the cohesive zone parameters from Double Cantilever Beam specimens loaded with pure moments is now well established and documented. However, for quasibrittle materials used in Civil Engineering such as concrete or wood, the difficulty to apply a pure bending moment lies inappropriated the method used for composites. Nevertheless, the one-to-one correspondence which exists between the R-curve and the softening curve is here revisited and adapted for any kind of specimen geometry and for the bilinear approximation of the softening function, well-known to successfully describe the failure of a wide group of quasibrittle materials. It is shown that even though the connections between the cohesive parameters and the ‘equivalent LEFM’ R-curve are geometry and material dependent, their trends are preserved whatever the specimen geometry and the material are. The outline of a general estimation procedure of the cohesive zone parameters funded on the equivalent LEFM R-curve is proposed

Mass and width of sigma(750) scalar meson from measurements of piN->pi(-)pi(+)N on polarized targets

The measurements of reactions $\pi^- p_\uparrow \to \pi^- \pi^+ n$ at 17.2 GeV/c and $\pi^+ n_\uparrow \to \pi^+ \pi^- p$ at 5.98 and 11.85 GeV/c made at CERN with polarized targets provide a model-independent and solution-independent evidence for a narrow scalar state sigma(750). The original chi^2 minimization method and the recent Monte Carlo method for amplitude analysis of data at 17.2 GeV/c are in excellent agreement. Both methods find that the mass distribution of the measured amplitude $|\overline S |^2\Sigma$ with recoil transversity ``up'' resonates near 750 MeV while the amplitude $|S|^2\Sigma$ with recoil transversity ``down'' is large and nonresonating. The amplitude $|S|^2\Sigma$ contributes as a strong background to S-wave intensity I_S = (|S|^2 + |\overline S |^2)\Sigma$and distorts the determinations of$\sigma$resonance parameters from$I_S$. To avoid this problem we perform a series of Breit-Wigner fits directly to the measured distribution$|\overline S |^2\Sigma$. The inclusion of various backgrounds causes the width of sigma(750) to become very narrow. Our best fit with$t$-averaged coherent background yields$m_\sigma = 753 \pm 19$MeV and$\Gamma_\sigma = 108 \pm 53$MeV. These values are in excellent agreement with Ellis-Lanik theorem for the width of scalar gluonium. The gluonium interpretation of$\sigma(750)$is also supported by the absence of$\sigma(750)$in reactions$\gamma\gamma \to \pi\pi$. We also show how data on polarized target invalidate essential assumptions of past determinations of$\pi\pi$ phase shifts .Comment: 77 page

Lancet

BACKGROUND: In 2015, the second cycle of the CONCORD programme established global surveillance of cancer survival as a metric of the effectiveness of health systems and to inform global policy on cancer control. CONCORD-3 updates the worldwide surveillance of cancer survival to 2014. METHODS: CONCORD-3 includes individual records for 37.5 million patients diagnosed with cancer during the 15-year period 2000-14. Data were provided by 322 population-based cancer registries in 71 countries and territories, 47 of which provided data with 100% population coverage. The study includes 18 cancers or groups of cancers: oesophagus, stomach, colon, rectum, liver, pancreas, lung, breast (women), cervix, ovary, prostate, and melanoma of the skin in adults, and brain tumours, leukaemias, and lymphomas in both adults and children. Standardised quality control procedures were applied; errors were rectified by the registry concerned. We estimated 5-year net survival. Estimates were age-standardised with the International Cancer Survival Standard weights. FINDINGS: For most cancers, 5-year net survival remains among the highest in the world in the USA and Canada, in Australia and New Zealand, and in Finland, Iceland, Norway, and Sweden. For many cancers, Denmark is closing the survival gap with the other Nordic countries. Survival trends are generally increasing, even for some of the more lethal cancers: in some countries, survival has increased by up to 5% for cancers of the liver, pancreas, and lung. For women diagnosed during 2010-14, 5-year survival for breast cancer is now 89.5% in Australia and 90.2% in the USA, but international differences remain very wide, with levels as low as 66.1% in India. For gastrointestinal cancers, the highest levels of 5-year survival are seen in southeast Asia: in South Korea for cancers of the stomach (68.9%), colon (71.8%), and rectum (71.1%); in Japan for oesophageal cancer (36.0%); and in Taiwan for liver cancer (27.9%). By contrast, in the same world region, survival is generally lower than elsewhere for melanoma of the skin (59.9% in South Korea, 52.1% in Taiwan, and 49.6% in China), and for both lymphoid malignancies (52.5%, 50.5%, and 38.3%) and myeloid malignancies (45.9%, 33.4%, and 24.8%). For children diagnosed during 2010-14, 5-year survival for acute lymphoblastic leukaemia ranged from 49.8% in Ecuador to 95.2% in Finland. 5-year survival from brain tumours in children is higher than for adults but the global range is very wide (from 28.9% in Brazil to nearly 80% in Sweden and Denmark). INTERPRETATION: The CONCORD programme enables timely comparisons of the overall effectiveness of health systems in providing care for 18 cancers that collectively represent 75% of all cancers diagnosed worldwide every year. It contributes to the evidence base for global policy on cancer control. Since 2017, the Organisation for Economic Co-operation and Development has used findings from the CONCORD programme as the official benchmark of cancer survival, among their indicators of the quality of health care in 48 countries worldwide. Governments must recognise population-based cancer registries as key policy tools that can be used to evaluate both the impact of cancer prevention strategies and the effectiveness of health systems for all patients diagnosed with cancer. FUNDING: American Cancer Society; Centers for Disease Control and Prevention; Swiss Re; Swiss Cancer Research foundation; Swiss Cancer League; Institut National du Cancer; La Ligue Contre le Cancer; Rossy Family Foundation; US National Cancer Institute; and the Susan G Komen Foundation

Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000–2014 (CONCORD-3)

Background: Survival is a key metric of the effectiveness of a health system in managing cancer. We set out to provide a comprehensive examination of worldwide variation and trends in survival from brain tumors in adults, by histology. Methods: We analyzed individual data for adults (15–99 years) diagnosed with a brain tumor (ICD-O-3 topography code C71) during 2000–2014, regardless of tumor behavior. Data underwent a 3-phase quality control as part of CONCORD-3. We estimated net survival for 11 histology groups, using the unbiased nonparametric Pohar Perme estimator. Results: The study included 556,237 adults. In 2010–2014, the global range in age-standardized 5-year net survival for the most common sub-types was broad: in the range 20%–38% for diffuse and anaplastic astrocytoma, from 4% to 17% for glioblastoma, and between 32% and 69% for oligodendroglioma. For patients with glioblastoma, the largest gains in survival occurred between 2000–2004 and 2005–2009. These improvements were more noticeable among adults diagnosed aged 40–70 years than among younger adults. Conclusions: To the best of our knowledge, this study provides the largest account to date of global trends in population-based survival for brain tumors by histology in adults. We have highlighted remarkable gains in 5-year survival from glioblastoma since 2005, providing large-scale empirical evidence on the uptake of chemoradiation at population level. Worldwide, survival improvements have been extensive, but some countries still lag behind. Our findings may help clinicians involved in national and international tumor pathway boards to promote initiatives aimed at more extensive implementation of clinical guidelines

Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000–14 (CONCORD-3) : analysis of individual data from 258 cancer registries in 61 countries

Background Leukaemias comprise a heterogenous group of haematological malignancies. In CONCORD-3, we analysed data for children (aged 0–14 years) and adults (aged 15–99 years) diagnosed with a haematological malignancy during 2000–14 in 61 countries. Here, we aimed to examine worldwide trends in survival from leukaemia, by age and morphology, in young patients (aged 0–24 years). Methods We analysed data from 258 population-based cancer registries in 61 countries participating in CONCORD-3 that submitted data on patients diagnosed with leukaemia. We grouped patients by age as children (0–14 years), adolescents (15–19 years), and young adults (20–24 years). We categorised leukaemia subtypes according to the International Classification of Childhood Cancer (ICCC-3), updated with International Classification of Diseases for Oncology, third edition (ICD-O-3) codes. We estimated 5-year net survival by age and morphology, with 95% CIs, using the non-parametric Pohar-Perme estimator. To control for background mortality, we used life tables by country or region, single year of age, single calendar year and sex, and, where possible, by race or ethnicity. All-age survival estimates were standardised to the marginal distribution of young people with leukaemia included in the analysis. Findings 164563 young people were included in this analysis: 121328 (73·7%) children, 22963 (14·0%) adolescents, and 20272 (12·3%) young adults. In 2010–14, the most common subtypes were lymphoid leukaemia (28205 [68·2%] patients) and acute myeloid leukaemia (7863 [19·0%] patients). Age-standardised 5-year net survival in children, adolescents, and young adults for all leukaemias combined during 2010–14 varied widely, ranging from 46% in Mexico to more than 85% in Canada, Cyprus, Belgium, Denmark, Finland, and Australia. Individuals with lymphoid leukaemia had better age-standardised survival (from 43% in Ecuador to ≥80% in parts of Europe, North America, Oceania, and Asia) than those with acute myeloid leukaemia (from 32% in Peru to ≥70% in most high-income countries in Europe, North America, and Oceania). Throughout 2000–14, survival from all leukaemias combined remained consistently higher for children than adolescents and young adults, and minimal improvement was seen for adolescents and young adults in most countries. Interpretation This study offers the first worldwide picture of population-based survival from leukaemia in children, adolescents, and young adults. Adolescents and young adults diagnosed with leukaemia continue to have lower survival than children. Trends in survival from leukaemia for adolescents and young adults are important indicators of the quality of cancer management in this age group.peer-reviewe

Malignant Tumors of the Central Nervous System

Malignant tumors of the central nervous system in adults comprise a heterogeneous group of malignancies, the largest subgroups comprising astrocytomas, ependymomas, and oligodendrogliomas. Glioblastomas are the most common tumor type, and they have dismal prognosis. Due to differences in cell type of origin, as well as pathogenesis, it is plausible that their etiology also differs between tumor types. The etiology of malignant CNS tumors is largely unknown and no occupational risk factors have been definitively identified. High doses of ionizing radiation increase the risk, but in occupational settings the dose levels appear too small to result in discernible excesses. Several studies have assessed possible effect of extremely low frequency and radiofrequency electromagnetic fields, but the results are inconsistent. Increased brain tumor risk has been reported in agricultural workers, but no specific exposure has been linked to them. Pesticides have been analyzed in several studies without showing a clear increase in risk.acceptedVersionPeer reviewe

Elastic layer model for application to crack propagation problems in timber engineering

A fracture mechanics model for analysis of crack initiation and propagation in wood is defined and applied. The model has the advantage of being simple, yet it enables reasonably general and accurate analysis commonly associated with more complex models. The present applied calculations are made by means of the finite element method and relate to progressive cleavage fracture along grain. The calculations concern a tapered double cantilever beam specimen and an end-notched beam. Comparisons are made of experimental test results. The fracture properties of the wood are modelled by means of a very thin linear elastic layer located along the crack propagation path. The properties of the layer are such that the strength and fracture energy of the wood are represented correctly. This makes a single linear elastic calculation sufficient for strength prediction. Both crack development and pre-existing cracks can be analyzed. Both material strength and fracture energy and stiffness are taken into account, their relative influence on structural strength being different for different elements. The fracture layer is in the finite element context represented by joint elements. Propagation of a crack can be analyzed either by a series of elastic calculations corresponding to different crack lengths or by use of a finite element code for non-linear analysis. The computational results include sensitivity analysis with respect to the influence of the various material parameters on structural strength

Influence of the fracture softening behaviour of wood on load-COD curve and R-curve

A cohesive crack model is used to analyse failure of wood in mode I along the grain. Several configurations of the gradual fracture softening behaviour of an interface, meshed with joint-elements located on the potential crack path, are investigated. Different constitutive laws, obtained from a single normalized polynomial function, are tested in order to estimate the influence of parameters such as, the tensile strength, the fracture energy or the ultimate opening of the interface, on the macroscopic response of a fracture specimen. Numerical results are compared with experimental data obtained on DCB specimen. We argue that the fracture energy related to the constitutive law must correspond to the plateau value of the R-curve. Moreover, this study reveals that the peak load of a load-COD (Crack Opening Displacement) curve is strongly affected by the slope of the softening behaviour. Finally, we present a review of the influence of each parameter describing the softening function on: (1) the load-COD curve and (2) the corresponding R-curve